Lupin has got the tentative approval from USFDA for its generic version of Diclofenac capsules that are used in pain management of osteoarthritis.

The company has said in a statement that the approval is for multiple strengths of 18 mg and 35 mg.

It added that Lupins Diclofenac capsules are generic versions of Iroko Pharmaceuticals LLC’s Zorvolex capsules of 18 mg and 35 MG.

For management of mild to moderate acute pain and management of osteoarthritis pain, the capsules are indicated.

Read EquityPandit’s Nifty Pharma Outlook for this week